Anzeige
Mehr »
Donnerstag, 23.04.2026 - Börsentäglich über 12.000 News
Gold konsolidiert bei $4.700 - doch dieser Entwickler trifft 9,9 g/t Gold über 7,0 Meter
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Sharecast

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiLondon open: FTSE steady after ceasefire extension, UK inflation print
MiEurope open: Shares up as Trump extends Iran war ceasefire
MiShoe Zone warns on profits amid weakening consumer confidence
MiSenior delivers 'good start' to FY26
MiTRIG sees no NAV hit from rise in govt electricity windfall tax
MiJD Sports chair Andrew Higginson to step down
MiBunzl holds guidance as Q1 revenue grows despite political uncertainty
MiUK inflation rises as global energy shock hits home
MiBunzl reiterates FY guidance, Senior FY performance seen ahead of previous expectations
MiLondon pre-open: Stocks to fall as investors mull ceasefire extension, UK inflation
MiWednesday newspaper round-up: SpaceX, airlines, PM Law, Kevin Warsh
DiUS close: Stocks slip ahead of ceasefire deadline
DiTrump says US will extend ceasefire with Iran
DiWednesday preview: UK inflation reading, Tesla and Boeing results due
DiEurope close: Stocks finish lower ahead of US-Iran ceasefire deadline
DiLondon close: Stocks sink to two-week low on Middle East caution, oil jumps late on
DiFTSE 100 movers: AB Foods slumps; British Land rallies after boosting guidance
DiBroker tips: JD Wetherspoons, S&U, Unilever
DiUS pending homes rise 1.5pc in March
DiEstee Lauder seeking funding for potential Puig takeover, Expansion reports
DiUS open: Stocks higher despite Middle East tensions, earnings take centre stage
DiAccsys flags record Accoya sales, strong revenue growth
DiFTSE 250 movers: Green shares spark on UK govt renewables move
DiRevolut aiming for up to $200bn valuation in 2028 listing - report
DiCrism reports positive preclinical results from prostate cancer model